Appraisal process documents

16/07/20

Letter from AWMSG to company following a NICE non-recommendation (PDF, 43Kb)

16/07/20

Recommendation wording (PDF, 403Kb)

16/07/20

Raising an issue during an appraisal (Word, 231Kb)

16/07/20

Information for companies attending AWMSG appraisal meetings (PDF, 518Kb)

16/07/20

Industry engagement (PDF, 477Kb)

16/07/20

AWMSG independent review process (PDF, 441Kb)

16/07/20

Guidance on appraisal structure and evidence considered (PDF, 780Kb)

16/07/20

Exclusion criteria to identify medicines outside AWMSG remit for appraisal (PDF, 430Kb)

16/07/20

Decision process for full and limited submissions (PDF, 371Kb)

16/07/20

Clinician and Patient Involvement Group (CAPIG) Terms of reference (PDF, 135Kb)

16/07/20

Clinician and Patient Involvement Group (CAPIG) fact sheet (PDF, 367Kb)

16/07/20

Appraisal process flow diagram and timeline (PDF, 385Kb)

16/07/20

Appraisal principles and process flowchart (PDF, 363Kb)

16/07/20

Appraisal process FAQs (PDF, 552Kb)

16/07/20

AWMSG appraisal process for a medicine for a rare disease (PDF, 500Kb)

16/07/20

AWMSG policy on appraising life-extending, end of life medicines (PDF, 467Kb)

16/07/20

Summary information for patients to be completed by the company (Word, 74Kb)

16/07/20

Clinical expert questionnaire and declarations of interest form (Word, 31Kb)

16/07/20

Budget impact template (Excel 2013, 622Kb)

16/07/20

Budget impact template (Excel 2003, 2Mb)